• <source id="eliry"><menuitem id="eliry"><em id="eliry"></em></menuitem></source>

        <b id="eliry"><tbody id="eliry"><sup id="eliry"></sup></tbody></b>
          <rp id="eliry"><menuitem id="eliry"></menuitem></rp>
            <source id="eliry"><nav id="eliry"></nav></source>
          <i id="eliry"><small id="eliry"></small></i>
          <cite id="eliry"><form id="eliry"><del id="eliry"></del></form></cite><i id="eliry"></i>
        1. <u id="eliry"><tbody id="eliry"><ol id="eliry"></ol></tbody></u><b id="eliry"></b>
        2. <video id="eliry"><menuitem id="eliry"></menuitem></video>
          <cite id="eliry"><tbody id="eliry"></tbody></cite>
          <b id="eliry"><address id="eliry"></address></b>
          +86 400-821-9890


          We are devoted to providing the most comprehensive and
          accurate molecular diagnostic information for every cancer
          patient and for physicians to help patients get
          personalized treatment.


          Genomic Testing

          We collaborate with hospitals and
          institutes by providing
          comprehensive genomic testing in
          our CLIA-certificated and CAP-
          accredited laboratory.


          We partner with pharmaceutical
          companies all over the world throughout
          research, biomarker-driven drug
          development and commercialization of
          new cancer therapies.

          Big Data Platform

          As one of the largest genomic
          datasets in China, we build datasets
          of Chinese cancer patients to
          advance medical research and new
          drug development.

          Genomic Testing

          We provide comprehensive tumor genomic testing to assist in personal treatment
          approaches that are recognized as targeted therapies and immunotherapies.

          Biomarker Discovery

          Fusion-Based Biomarkers
          for Targeted Therapy

          We have integrated DNA and RNA sequencing results
          for detection of fusion genes with higher sensitivity.

          IO Biomarkers

          We have leveraged multiple techniques (DNA, RNA,
          IHC, etc.) to help identify immunotherapy-related
          biomarkers for our patients.


          OrigiMed has 43,000 square feet of lab
          space which has been built in line with
          international standards and 54,000 sq.ft
          of office space.

          43,000 sq.ftLab Space
          4PBStorage Capacity
          110 TFLOPSTotal Peak Performance
          2,304 CoresCPU Core Number
          20.4 TBTotal Memory


          by The College of
          American Pathologists

          by The Centers for
          Medicare & Medicaid


          CSCO-OrigiMed Cancer
          Genomics Data
          Platform for Chinese
          cancer patients

          New Clinical Trial
          Sharing Platform

          摩臣2娱乐 936| 275| 899| 458| 508| 913| 96| 117| 877| 927| 271| 69| 478| 668| 953| 528| 239| 751| 392| 648| 520| 784| 338| 309| 994| 771| 230| 915| 473| 159| 592| 856| 158| 529| 710| 891| 874| 192| 183| 599| 470|